SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 62 filers reported holding SATSUMA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $115 | -49.8% | 164,500 | -35.3% | 0.00% | – |
| Q4 2022 | $229 | -99.6% | 254,100 | +2441.0% | 0.00% | – |
| Q3 2022 | $60,000 | -69.1% | 10,000 | -76.0% | 0.00% | – |
| Q3 2021 | $194,000 | -52.1% | 41,664 | -27.5% | 0.00% | -100.0% |
| Q2 2021 | $405,000 | -29.3% | 57,479 | -40.7% | 0.00% | 0.0% |
| Q1 2021 | $573,000 | +574.1% | 97,000 | +426.5% | 0.00% | – |
| Q4 2020 | $85,000 | – | 18,425 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,118,761 | $14,533,000 | 3.83% |
| Ghost Tree Capital, LLC | 904,225 | $4,214,000 | 1.23% |
| RA Capital Management | 5,914,252 | $27,560,000 | 0.38% |
| Vivo Capital, LLC | 1,232,394 | $5,743,000 | 0.26% |
| Nan Fung Group Holdings Ltd | 142,900 | $666,000 | 0.21% |
| Ikarian Capital, LLC | 629,384 | $2,934,000 | 0.21% |
| NEA Management Company, LLC | 3,142,958 | $14,646,000 | 0.17% |
| SAMLYN CAPITAL, LLC | 1,716,067 | $7,998,000 | 0.11% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $8,788,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 90,665 | $422,000 | 0.04% |